Product
LCAR-G08
1 clinical trial
1 indication
Indication
Advanced Gastrointestinal TumorsClinical trial
A Phase 1, Open-Label Study Evaluating the Safety, Tolerability and Efficacy of (LCAR)-G08, a Chimeric Antigen Receptor (CAR)-T Cell Therapy Targeting Guanylyl Cyclase C (GCC) in Subjects With Advanced Gastrointestinal TumorsStatus: Recruiting, Estimated PCD: 2025-11-01